The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...

LITTLETON, Colo., Dec. 23, 2024 (GLOBE NEWSWIRE) -- . (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization ...

Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Two U.S. Navy pilots ejected from their jet fighter over the Red Sea after being caught in "an apparent case of friendly-fire," U.S. Central Command said Sunday, as American forces conducted a new ...

If you can usually finish a run with ease, but are suddenly hit with severe fatigue, it could be a subtle sign of an ...

In another milestone, Eli Lilly's weight-loss medication, Zepbound, received FDA approval, marking it as the first drug to specifically tackle moderate to severe obstructive sleep apnea in obese ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood ...

Perhaps the most alarming sound is loud, gasping snores punctuated by choking. This pattern often signals obstructive sleep ...

The open-label Phase IIIb SURMOUNT-5 trial (NCT05822830) enrolled 751 obese or overweight participants with at least one of the comorbidities such as hypertension, dyslipidemia, obstructive sleep ...